PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The current study is being conducted to evaluate the relative bioavailability and single- and
multiple-dose pharmacokinetics of encapsulated mesalamine granules(eMG) in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.